Darolutamide Plus ADT in Metastatic Hormone-Sensitive Prostate Cancer

(MedPage Today) — New data presented at the American Urological Association (AUA) annual meeting further supported the use of darolutamide (Nubeqa) in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive…

Source link : https://www.medpagetoday.com/meetingcoverage/auavideopearls/115825

Author :

Publish date : 2025-05-30 17:50:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Darolutamide Plus ADT in Metastatic Hormone-Sensitive Prostate Cancer

CDC Now Advises Shared Decision-Making for Kids’ COVID Shots

COVID Vaccine Guidance in Pregnancy Has Shifted — But the Science Hasn’t

Related Posts

Major Medical Groups Pushed Out of Role Supporting CDC’s Vaccine Advisors

‘It’s Gonna Be (Ly)me’: Justin Timberlake Brings Attention, Awareness to Disease

ACOG No Longer Accepting Federal Funding, Citing Policy Disputes

States Sue Trump, Say Targeting of Hospitals Over Gender Care in Minors Is Unlawful

Time Your Meals, Tune Your Metabolism

Novel Eye Drops for Age-Related Blurry Vision Win FDA Approval

Major Medical Groups Pushed Out of Role Supporting CDC’s Vaccine Advisors

‘It’s Gonna Be (Ly)me’: Justin Timberlake Brings Attention, Awareness to Disease

ACOG No Longer Accepting Federal Funding, Citing Policy Disputes

States Sue Trump, Say Targeting of Hospitals Over Gender Care in Minors Is Unlawful

Time Your Meals, Tune Your Metabolism

Novel Eye Drops for Age-Related Blurry Vision Win FDA Approval

Bone Health in Duchenne Muscular Dystrophy

Could we get quantum spookiness even without entanglement?

Categories

Archives